Failure to progress autoflush & burette is apparently due to dominant suppliers shutting us out. It has come back to life with a current qld hospital trial plus negotiations for a potential license/sale.
These negotiations are mainly for Pericoach and I expect a result in 2nd half '18, possibly sooner. V3 PeriCoach has very many factors in its favor, and would be of great benefit to half the worlds population. But ALT is a minnow lacking cash and skill to commercialise the brilliant products.
HOWEVER, A FUNDAMENTAL CHANGE OCCURRED when one Peter Corr came along as cornerstone investor then Director and began steering direction. I think 'absolutely clueless' informed us he was an old school mate of MM's - what luck for us! One of the major benefits is he's given us the ability to have a major global corporate adviser handling negotiations, one that wouldn't normally waste time on an asx micro.
Little ALT has brought its giant to the fray!
ALT Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
